Avalo Therapeutics Inc (AVTX)

Nov 17, 2024

(AVTX) Investment Analysis and Advice - Stock Traders Daily

Nov 17, 2024

Nov 15, 2024

Orbimed Advisors LLC Acquires New Stake in Avalo Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Avalo Therapeutics director June Almenoff acquires $12,749 in stock - Investing.com

Nov 14, 2024

Nov 13, 2024

Avalo Therapeutics secures $69.4 million from warrant exercise By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

Avalo Therapeutics Closes $69.4 Million Financing - citybiz

Nov 12, 2024

Nov 12, 2024

Avalo Therapeutics receives $69.4M in proceeds from exercise of warrants - TipRanks

Nov 12, 2024

Nov 12, 2024

Avalo Therapeutics secures $69.4 million from warrant exercise - Investing.com India

Nov 12, 2024

Nov 12, 2024

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants - GlobeNewswire Inc.

Nov 12, 2024

Nov 11, 2024

Avalo Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Nov 11, 2024

Nov 07, 2024

Avalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year - TipRanks

Nov 07, 2024

Nov 07, 2024

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Avalo Therapeutics Inc (AVTX) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 06, 2024

Where are the Opportunities in (AVTX) - Stock Traders Daily

Nov 06, 2024

Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024

Oct 26, 2024

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at HC Wainwright - Defense World

Oct 26, 2024

Oct 15, 2024

When (AVTX) Moves Investors should Listen - Stock Traders Daily

Oct 15, 2024

Oct 08, 2024

Avalo Therapeutics begins Phase 2 trial for hidradenitis suppurativa - Investing.com

Oct 08, 2024

Oct 08, 2024

Avalo Therapeutics maintains Outperform rating from Oppenheimer - Investing.com

Oct 08, 2024

Oct 08, 2024

Avalo Therapeutics begins Phase 2 trial for hidradenitis suppurativa By Investing.com - Investing.com UK

Oct 08, 2024

Oct 08, 2024

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial - GlobeNewswire

Oct 08, 2024

Oct 08, 2024

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa - Yahoo Finance

Oct 08, 2024

Oct 08, 2024

Ikarian Capital, LLC Adjusts Stake in Avalo Therapeutics Inc - GuruFocus.com

Oct 08, 2024

Oct 05, 2024

(AVTX) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 05, 2024

Sep 27, 2024

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Expands By 38.1% - Defense World

Sep 27, 2024

Sep 25, 2024

Avalo Therapeutics: Pioneering Biotech Solutions for Immune Disorders - The China Perspective

Sep 25, 2024

Sep 25, 2024

Affinity Asset Advisors LLC Acquires 35,000 Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Sep 25, 2024

Sep 24, 2024

Logos Global Management LP Purchases New Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Sep 24, 2024

Sep 13, 2024

How To Trade (AVTX) - Stock Traders Daily

Sep 13, 2024

Sep 10, 2024

Avalo Therapeutics (NASDAQ:AVTX) Stock Price Up 7.8% - Defense World

Sep 10, 2024

Sep 04, 2024

Avalo Therapeutics regains Nasdaq compliance - Investing.com

Sep 04, 2024

Sep 04, 2024

Avalo Announces Participation in September Investor Conferences - GlobeNewswire

Sep 04, 2024

Sep 02, 2024

Financial Health Report: Avalo Therapeutics Inc (AVTX)’s Ratios Tell a Tale - The Dwinnex

Sep 02, 2024

Aug 29, 2024

Trading (AVTX) With Integrated Risk Controls - Stock Traders Daily

Aug 29, 2024

Aug 19, 2024

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 9.6% in July - Defense World

Aug 19, 2024

Aug 18, 2024

Avalo Therapeutics (FRA:C6K0) Cash From Discontinued Investing Activities : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 18, 2024

Aug 15, 2024

Oppenheimer sees upside in Avalo Therapeutics stock as phase 2 trial nears - Investing.com

Aug 15, 2024

Aug 14, 2024

Avalo Therapeutics (NASDAQ:AVTX) Releases Earnings Results - Defense World

Aug 14, 2024

Aug 14, 2024

Avalo Therapeutics Shareholders Back Board and Strategies - TipRanks

Aug 14, 2024

Aug 13, 2024

Avalo Therapeutics sees cash runway into 2027 - TipRanks

Aug 13, 2024

Aug 12, 2024

AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024 - InvestorPlace

Aug 12, 2024

Aug 12, 2024

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates - citybiz

Aug 12, 2024

Aug 09, 2024

Avalo Therapeutics Inc expected to post a loss of $6.70 a shareEarnings Preview - XM

Aug 09, 2024

Jul 28, 2024

Natixis Lowers Stake in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World

Jul 28, 2024

Jul 26, 2024

(AVTX) Long Term Investment Analysis - Stock Traders Daily

Jul 26, 2024

Jul 24, 2024

The 3 Best Personalized Nutrition Stocks to Buy Now - InvestorPlace

Jul 24, 2024

Jul 24, 2024

Avalo Therapeutics (NASDAQ:AVTX) Shares Down 2.1% - Defense World

Jul 24, 2024

Jul 16, 2024

Avalo Therapeutics welcomes new Chief Medical Officer - Investing.com

Jul 16, 2024

Jul 16, 2024

Avalo Therapeutics Welcomes Chief Medical Officer - Contract Pharma

Jul 16, 2024

Jul 16, 2024

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer - GlobeNewswire Inc.

Jul 16, 2024